Intended for healthcare professionals

CCBYNC Open access
Research

Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k2644 (Published 11 July 2018) Cite this as: BMJ 2018;362:k2644

Looking forward to longer term follow up study

Very interesting findings. Will be eagerly awaiting a follow up analysis in another 20 years or so as the majority of the study population has not yet reached the age of "average" diagnosis of breast and ovarian cancers (60s). It will be interesting to see, if at that time, the invasive breast cancer rates actually do increase beyond the average anticipated percentage of the cohort. In addition, it would be interesting to see similar risk analysis of women who have undergone oocyte donation cycles as they are less likely to have female infertility issues, but may be at increased risk of breast, uterine or ovarian cancers as well.

Competing interests: No competing interests

19 July 2018
Erika Spaeth
Clinical Affairs
Phenogen Sciences